Abstract:Objective: To assess the impact of below-benchmark (95%-100%) donor-oocyte survival rates on vitrification/warming in the laboratory and clinical outcomes of recipient cycles. Design: Retrospective cohort study. Setting: A network of European private in vitro fertilization units. Patient(s): We analyzed 12,690 vitrified-warmed donor-oocyte recipient cycles performed from 2018-2022. Intervention(s): All cycles analyzed used exclusively vitrified/warmed donor oocytes. The cycles were grouped according to the survival rate experienced: benchmark 95%-100%; competence 85%-95%; below competence 70%-85%; poor 50%-70%; and very poor <50%. Main outcome measure(s): The primary endpoint of the study was the total usable blastocyst rate per 2 pronuclear (2PN) zygote. Secondary endpoints were the fertilization rate, the live birth rate after the first single blastocyst transfer, and the cumulative live birth rate. Result(s): The mean number of warmed oocytes per intracytoplasmic sperm injection (ICSI) cycle was 11.4 ± 3.2, with a mean survival rate of 89.1%. More oocytes per cycle were consumed in the lower survival groups, yet the total number of oocytes available for ICSI was smaller in the below-competence, poor, and very poor survival groups. The total usable blastocyst rate was lower in the lower survival groups (benchmark: 48.9%; competence: 47.0%, below competence: 46.0%; poor: 43.6%; and very poor: 43.6%), as well as the fertilization rates (benchmark: 76.8%; competence: 76.6%, below competence: 75.6%; poor: 74.7%; and very poor:75.5%). The adjusted relative risk (aRR) of live birth rate of the first embryo transferred was equal to the benchmark survival group in all the lower survival groups (benchmark: 40.9%; competence: aRR = 0.986, 95% confidence interval [CI]: 0.931-1.045; below-competence: aRR = 0.992, 95% CI: 0.929-1.059; poor: aRR = 1.103, 95% CI: 1.009-1.207; and very poor: aRR = 1.169, 95% CI: 0.963-1.419). The cumulative live birth rate decreased in lower survival groups compared with benchmark survival (benchmark: 79.2%; competence: aRR = 0.988, 95% CI: 0.961-1.015; below competence: aRR = 0.911, 95% CI: 0.880-0.944; poor: aRR = 0.802, 95% CI: 0.757-0.851; and very poor: aRR = 0.793, 95% CI: 0.693-0.907). The lower cumulative rates maintained in a subanalysis with equal metaphase-II available for ICSI (benchmark: 69.5%; competence: aRR = 0.909, 95% CI: 0.827-1.000; below competence: aRR = 0.942, 95% CI: 0.848-1.046; poor: aRR = 0.833, 95% CI: 0.7386-0.941; and very poor: aRR = 0.873, 95% CI: 0.695-1.097) CONCLUSIONS: Lower donor-oocyte cryo-survival rates have a moderate negative impact on the blastocyst utilization rate per 2PN zygote, fertilization rate, and the cumulative live birth rates of a donation cycle, even after adjusting for equal metaphase-II oocytes available for ICSI. Nonetheless, the surviving oocytes of a cohort seem to maintain a high competence level, with very similar laboratory outcomes, irrespective of the cohort's survival rates, as well as equal implantation potential of the resulting blastocysts.

"Try until the last?"—the relevance of fresh embryo transfer outcomes for subsequent same-cohort vitrified–warmed cycles

Association of the duration of post-thaw culture with clinical outcome after vitrified-warmed day 3 embryo transfer in 10,464 cycles: A retrospective cohort study.

Influence of Cleavage-Stage Embryo Quality on the In-Vitro Fertilization Outcome after Single Embryo Transfer in Fresh Cycles.

Clinical outcomes after elective double-embryo transfer in frozen cycles for women of advanced maternal age A retrospective cohort study

Live Birth after Fresh Versus Frozen Single Blastocyst Transfer (Frefro-Blastocyst): Study Protocol for a Randomized Controlled Trial

A Comparison of Implantation, Miscarriage and Pregnancy Rates of Single and Double Day 3 Embryo Transfer Between Fresh and Frozen Thawed Transfer Cycles: a Retrospective Study.

Clinical outcomes after elective double-embryo transfer in frozen cycles for women of advanced maternal age

Predictive Value of the Number of Frozen Blastocysts in Live Birth Rates of the Transferred Fresh Embryos

Patient- and cycle-specific factors affecting the outcome of frozen-thawed embryo transfers

Factors influencing the outcomes of the vitrified frozen-thawed embryo transfer

The reproductive potential of vitrified-warmed euploid embryos declines following repeated uterine transfers

Competent blastocyst and receptivity endometrium improved clinical pregnancy in fresh embryo transfer cycles: a retrospective cohort study

Effect of pregnancy outcome of the first IVF/ICSI embryo transfer cycle on the next frozen-thawed embryo transfer cycle

An Appraisal of Current Embryo Transfer Strategies

Fresh vs. frozen embryo transfer: new approach to minimize the limitations of using national surveillance data for clinical research

Birth of Thirty-Two Healthy Babies Following Transfer of Fresh and Frozen-Thawed Embryos Derived from Monopronuclear Zygotes: A Retrospective Study

When the Embryo Meets the Endometrium: Identifying the Features Required for Successful Embryo Implantation

Embryo Cryopreservation Strategy May Improve Live Birth for Women Underwent In Vitro Maturation After Early Oocyte Retrieval: A Retrospective Cohort Study

Assessing the effect of below-benchmark vitrified/warmed donor-oocyte survival rates in subsequent laboratory and clinical outcomes

Long-term Embryo Vitrification is Associated with Reduced Success Rates in Women Undergoing Frozen Embryo Transfer Following a Failed Fresh Cycle

Similar pregnancy outcomes from fresh and frozen donor oocytes transferred to gestational carriers: a SART database analysis isolating the effects of oocyte vitrification